Suminguit, Leonor G.

HRN: 23-82-12  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/14/2023
10/21/2023
IV
500mg
Q8h
Amoebiasis
Checking Final Appropriateness 
10/18/2023
METRONIDAZOLE 500MG (TAB)
10/18/2023
10/23/2023
ORAL
500mg/tab
TID
Intestinal Amoebiasis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: